Healthcare facilities across the nation, especially hospitals and nursing homes, are facing a significant threat from a rapidly spreading fungus, Candida auris. This drug-resistant yeast poses specific challenges in states like New York and New Jersey, indicating an imminent threat to public health. The rapid proliferation of Candida auris has prompted the Centers for Disease…
In the sphere of healthcare, infection prevention professionals are witnessing an alarming surge of an invasive, drug-resistant fungus, Candida auris (C. auris), often described as a 'superbug.' Recognized for its rapid spread through U.S. healthcare institutions and growing threat worldwide, this contagion's resistance to drugs has strengthened over the years. The American Society of Microbiology…
For over a decade, healthcare facilities in the United States have been grappling with the specter of carbapenem-resistant Enterobacterales (CRE). This group of bacteria has returned with a vengeance, thanks to the rise of the New Delhi metallo-β-lactamase-producing CRE (NDM-CRE), a formidable foe resistant to multiple therapeutic options.
The Centers for Disease Control and Prevention (CDC)…
In a crucial five-year study conducted between 2019 and 2023, a team of researchers led by Hui Zeng investigated the distribution and resistance patterns of different pathogens in the Intensive Care Unit (ICU) of a newly established hospital in Guizhou Province, China. This significant endeavor was aimed at promoting the rational use of antibiotics to…
Biofilm-producing bacteria linked to wound infections pose a significant clinical challenge due to their exceptional resistance to drugs. This resistance contributes to increased morbidity, adverse outcomes such as delayed healing, and escalated healthcare costs. Bacterial wound infections, with an intensifying prevalence of multi-drug resistant bacteria, necessitate the formulating of evidence-based decision-making processes, particularly in resource-limited…
This article synthesizes findings of a comprehensive, seven-year (2016-2022) multi-center study that investigated the pathogen distribution and drug resistance of gram-negative bacteria causing bloodstream infections (BSIs) amongst pediatric patients in China.
The research was facilitated by the Infectious Disease Surveillance of Pediatric (ISPED), whose reach expanded to 12 tertiary children’s hospitals in nine provinces or…